The abstract is read at the publisher; the summary is JClub's.
SLC26A6 is identified as a direct selenite transporter that promotes selenoprotein translation, redox homeostasis, and ferroptosis resistance.
- Why it matters: Uptake of inorganic selenium is only partially understood, limiting mechanistic and therapeutic control over how selenium supports selenoprotein synthesis and cellular stress protection.
- What they did: A CRISPR-based loss-of-function screen followed by biochemical, cellular, and in vivo experiments established SLC26A6-mediated selenite transport and downstream functional effects.
- The result: A first human-specific SLC26A6 inhibitor was reported, and cryo-electron microscopy resolved the SLC26A6–inhibitor complex, enabling pharmacological targeting of selenium uptake and ferroptosis resistance.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.